Mustang Bio, Inc. (MBIO) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Mustang Bio, Inc. (MBIO) Bundle
Looking to assess Mustang Bio, Inc.'s intrinsic value? Our MBIO DCF Calculator integrates real-world data with extensive customization options, allowing you to adjust forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -43.3 | -54.3 | -64.0 | -71.1 | -48.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 1.4 | 1.8 | 2.3 | 3.0 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -44.6 | -56.1 | -66.4 | -74.2 | -50.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 61.4 | 97.8 | 109.6 | 75.7 | 6.2 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .1 | .3 | 3.9 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.9 | 3.5 | 3.5 | 6.8 | 6.3 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -3.7 | -4.4 | -5.4 | -3.1 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -46.3 | -58.1 | -64.1 | -75.5 | -50.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -46.8 | -59.1 | -67.2 | -72.4 | -52.3 | -2.4 | .0 | .0 | .0 | .0 |
| WACC, % | 37.45 | 37.45 | 36.34 | 37.45 | 37.45 | 37.23 | 37.23 | 37.23 | 37.23 | 37.23 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | 2 | |||||||||
| Diluted Shares Outstanding, MM | 9 | |||||||||
| Equity Value Per Share | 0.23 |
What You Will Receive
- Pre-Filled Financial Model: Mustang Bio, Inc.'s (MBIO) actual data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
- Real-Time Calculations: Automatic updates ensure immediate visibility of results as adjustments are made.
- Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
- Customizable and Reusable: Designed for adaptability, allowing for repeated use in comprehensive forecasts.
Key Features
- 🔍 Real-Life MBIO Financials: Pre-filled historical and projected data for Mustang Bio, Inc. (MBIO).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Mustang Bio’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Mustang Bio’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring Mustang Bio, Inc. (MBIO) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Mustang Bio, Inc. (MBIO)'s intrinsic value.
- Step 5: Make informed investment decisions or create reports based on the outputs.
Why Choose Mustang Bio, Inc. (MBIO)?
- Innovative Solutions: Cutting-edge therapies developed to address unmet medical needs.
- Proven Expertise: A team of experienced professionals dedicated to advancing biotechnology.
- Robust Pipeline: Diverse portfolio of candidates in various stages of development.
- Commitment to Quality: Adherence to the highest standards in research and manufacturing processes.
- Positive Impact: Focused on improving patient outcomes and transforming lives.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing Mustang Bio, Inc. (MBIO) investments.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Mustang Bio, Inc. (MBIO).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like Mustang Bio, Inc. (MBIO) are valued in the marketplace.
What the Template Contains
- Historical Data: Includes Mustang Bio, Inc.'s (MBIO) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Mustang Bio, Inc.'s (MBIO) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Mustang Bio, Inc.'s (MBIO) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.